# Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases

Page: https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep195-ken-song-on-t-cell-engagers-for-autoimmune-diseases
Text version: https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep195-ken-song-on-t-cell-engagers-for-autoimmune-diseases.md
Podcast: [The Long Run with Luke Timmerman](https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799)
Published: 2026-03-03T13:30:56+00:00
Episode link: https://soundcloud.com/longrunpodcast/ep195-ken-song-on-t-cell
Audio file: https://feeds.soundcloud.com/stream/2276762408-longrunpodcast-ep195-ken-song-on-t-cell.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep195-ken-song-on-t-cell-engagers-for-autoimmune-diseases
Duration seconds: 3945

## Resource

Ken Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep195-ken-song-on-t-cell-engagers-for-autoimmune-diseases/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep195-ken-song-on-t-cell-engagers-for-autoimmune-diseases.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.